Alnylam Pharmaceuticals
ALNY
#625
Rank
A$50.28 B
Marketcap
$389.84
Share price
1.06%
Change (1 day)
40.23%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: A$50.28 Billion

As of December 2024 Alnylam Pharmaceuticals has a market cap of A$50.28 Billion. This makes Alnylam Pharmaceuticals the world's 625th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2024

End of year Market Cap

Year Marketcap Change
2024A$50.28 B42.61%
2023A$35.25 B-17.94%
2022A$42.96 B53.58%
2021A$27.97 B42.46%
2020A$19.63 B6.41%
2019A$18.45 B76.24%
2018A$10.47 B-35.12%
2017A$16.13 B262.08%
2016A$4.45 B-59.46%
2015A$10.99 B20.17%
2014A$9.15 B99.14%
2013A$4.59 B398.47%
2012A$0.92 B171.43%
2011A$0.33 B-17.37%
2010A$0.41 B-49.91%
2009A$0.82 B-43.47%
2008A$1.45 B7.04%
2007A$1.35 B34.83%
2006A$1.00 B185.67%
2005A$0.35 B89.15%
2004A$0.18 B

End of Day market cap according to different sources

On Dec 17th, 2024 the market cap of Alnylam Pharmaceuticals was reported to be:

A$50.28 Billion
by Yahoo Finance info icon info icon
A$50.28 Billion
by CompaniesMarketCap info icon info icon
A$50.28 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
A$4.38 B-91.29%๐Ÿ‡บ๐Ÿ‡ธ USA
A$128.56 B 155.69%๐Ÿ‡บ๐Ÿ‡ธ USA
A$18.99 B-62.23%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.71 B-96.59%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.16 B-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
A$316.10 B 528.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$197.38 B 292.56%๐Ÿ‡ซ๐Ÿ‡ท France
A$37.40 B-25.61%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel